CompletedPhase 2NCT00104949

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

Studying Synovial sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
SWOG Cancer Research Network
Principal Investigator
Ernest C. Borden, MD
The Cleveland Clinic
Intervention
trastuzumab(biological)
Enrollment
40 target
Eligibility
18 years · All sexes
Timeline
2005 – 2007

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00104949 on ClinicalTrials.gov

Other trials for Synovial sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Synovial sarcoma →

← Back to all trials